Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-03-003522
Filing Date
2003-03-21
Accepted
2003-03-21 16:09:51
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 NOVEN PHARMACEUTICALS INC. g81253e10vk.htm 10-K 892484
3 EX-10.25 TRASACTION AGREEMENT g81253exv10w25.txt EX-10.25 321807
4 EX-11 COMPUTATION OF EARNINGS PER SHARE g81253exv11.txt EX-11 1716
5 EX-21 SUBSIDIARIES OF THE REGISTRANT g81253exv21.txt EX-21 346
6 EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP g81253exv23w1.txt EX-23.1 798
7 EX-23.2 CONSENT OF PRICEWATERHOUSECOOPERS LLP g81253exv23w2.txt EX-23.2 549
8 EX-99.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER g81253exv99w1.txt EX-99.1 3194
9 EX-99.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER g81253exv99w2.txt EX-99.2 3138
  Complete submission text file 0000950144-03-003522.txt   1226529
Mailing Address 11960 SW 144TH STREET MIAMI FL 33185
Business Address 11960 SW 144TH ST MIAMI FL 33186 3052535099
NOVEN PHARMACEUTICALS INC (Filer) CIK: 0000815838 (see all company filings)

EIN.: 592767632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-17254 | Film No.: 03612497
SIC: 2834 Pharmaceutical Preparations